Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Maftei

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Medicinal Chemistry|July 15, 2017
Targeting the Prokineticin System to Control Chronic Pain and InflammationLucia Negri, Daniela Maftei
Frontiers in Pharmacology|June 25, 2019
Chemokines in Alzheimer's Disease: New Insights Into Prokineticins, Chemokine-Like ProteinsAnna Rita Zuena, Paola Casolini, Roberta Lattanzi, et al.
Neuropeptides|December 17, 2018
Identification and characterization of Prokineticin receptor 2 splicing variant and its modulation in an animal model of Alzheimer's diseaseRoberta Lattanzi, Daniela Maftei, Maria Rosaria Fullone, et al.
Cell Biochemistry and Function|September 6, 2020
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 bindingRoberta Lattanzi, Daniela Maftei, Maria Rosaria Fullone, et al.
Frontiers in Pharmacology|March 18, 2021
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological ProcessesRoberta Lattanzi, Cinzia Severini, Daniela Maftei, et al.
Neuropeptides|September 27, 2018
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptorRoberta Lattanzi, Daniela Maftei, Lucia Negri, et al.
Life (Basel, Switzerland)|February 25, 2022
Identification and Characterization of a New Splicing Variant of Prokineticin 2Roberta Lattanzi, Daniela Maftei, Martina Vincenzi, et al.
Biomolecules|March 25, 2022
Identification of Regions Involved in the Physical Interaction between Melanocortin Receptor Accessory Protein 2 and Prokineticin Receptor 2Maria Rosaria Fullone, Daniela Maftei, Martina Vincenzi, et al.
Current Neuropharmacology|April 12, 2022
Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative DiseasesDaniela Maftei, Tommaso Schirinzi, Nicola B Mercuri, et al.
International Journal of Molecular Sciences|September 9, 2022
Arginine 125 Is an Essential Residue for the Function of MRAP2Maria Rosaria Fullone, Daniela Maftei, Martina Vincenzi, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Medicinal Chemistry|July 15, 2017
Targeting the Prokineticin System to Control Chronic Pain and InflammationLucia Negri, Daniela Maftei
Frontiers in Pharmacology|June 25, 2019
Chemokines in Alzheimer's Disease: New Insights Into Prokineticins, Chemokine-Like ProteinsAnna Rita Zuena, Paola Casolini, Roberta Lattanzi, et al.
Neuropeptides|December 17, 2018
Identification and characterization of Prokineticin receptor 2 splicing variant and its modulation in an animal model of Alzheimer's diseaseRoberta Lattanzi, Daniela Maftei, Maria Rosaria Fullone, et al.
Cell Biochemistry and Function|September 6, 2020
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 bindingRoberta Lattanzi, Daniela Maftei, Maria Rosaria Fullone, et al.
Frontiers in Pharmacology|March 18, 2021
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological ProcessesRoberta Lattanzi, Cinzia Severini, Daniela Maftei, et al.
Neuropeptides|September 27, 2018
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptorRoberta Lattanzi, Daniela Maftei, Lucia Negri, et al.
Life (Basel, Switzerland)|February 25, 2022
Identification and Characterization of a New Splicing Variant of Prokineticin 2Roberta Lattanzi, Daniela Maftei, Martina Vincenzi, et al.
Biomolecules|March 25, 2022
Identification of Regions Involved in the Physical Interaction between Melanocortin Receptor Accessory Protein 2 and Prokineticin Receptor 2Maria Rosaria Fullone, Daniela Maftei, Martina Vincenzi, et al.
Current Neuropharmacology|April 12, 2022
Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative DiseasesDaniela Maftei, Tommaso Schirinzi, Nicola B Mercuri, et al.
International Journal of Molecular Sciences|September 9, 2022
Arginine 125 Is an Essential Residue for the Function of MRAP2Maria Rosaria Fullone, Daniela Maftei, Martina Vincenzi, et al.
Pageof 5